<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37396577</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Editorial: COVID-19 and thrombo-inflammatory responses.</ArticleTitle><Pagination><StartPage>1231909</StartPage><MedlinePgn>1231909</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1231909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2023.1231909</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Subramaniam</LastName><ForeName>Saravanan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pulmonary Center, Department of Medicine, Chobanian &amp; Avedisian School of Medicine, Boston University, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhardt</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site RhineMain, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Paresh P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiezia</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Thrombosis and Hemorrhagic Diseases Unit Medicine, Padova University Hospital, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">VITT</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">platelets and COVID-19</Keyword><Keyword MajorTopicYN="N">thrombo-inflammation</Keyword><Keyword MajorTopicYN="N">thrombocytopenia</Keyword><Keyword MajorTopicYN="N">thromboprophylaxis regimens</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37396577</ArticleId><ArticleId IdType="pmc">PMC10311441</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2023.1231909</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. (2020) 51:613&#x2013;28. 10.1007/s10735-020-09915-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10735-020-09915-3</ArticleId><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol. (2020) 45:100618. 10.1016/j.cpcardiol.2020.100618</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100618</ArticleId><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. (2020) 192:152&#x2013;60. 10.1016/j.thromres.2020.05.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.05.039</ArticleId><ArticleId IdType="pmc">PMC7255332</ArticleId><ArticleId IdType="pubmed">32485418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. (2020) 324:799&#x2013;801. 10.1001/jama.2020.13372</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S, Kothari H, Bosmann M. Tissue factor in COVID-19-associated coagulopathy. Thromb Res. (2022) 220:35&#x2013;47. 10.1016/j.thromres.2022.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.09.025</ArticleId><ArticleId IdType="pmc">PMC9525243</ArticleId><ArticleId IdType="pubmed">36265412</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S, Ruf W, Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol. (2022) 179(10):2086&#x2013;99. 10.1111/bph.15587</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15587</ArticleId><ArticleId IdType="pmc">PMC8794588</ArticleId><ArticleId IdType="pubmed">34235728</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Li X, Shi X, Zhu M, Wang J, Huang S, et al. Platelet integrin alphaIIbbeta3: signal transduction, regulation, and its therapeutic targeting. J Hematol Oncol. (2019) 12:26. 10.1186/s13045-019-0709-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-019-0709-6</ArticleId><ArticleId IdType="pmc">PMC6407232</ArticleId><ArticleId IdType="pubmed">30845955</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett JA, Ture SK, Schmidt RA, Mastrangelo MA, Cameron SJ, Terry LE, et al. Acetylcholine inhibits platelet activation. J Pharmacol Exp Ther. (2019) 369:182&#x2013;7. 10.1124/jpet.118.253583</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.118.253583</ArticleId><ArticleId IdType="pmc">PMC6439456</ArticleId><ArticleId IdType="pubmed">30765424</ArticleId></ArticleIdList></Reference><Reference><Citation>Schedel A, Thornton S, Schloss P, Kluter H, Bugert P. Human platelets express functional alpha7-nicotinic acetylcholine receptors. Arterioscler Thromb Vasc Biol. (2011) 31:928&#x2013;34. 10.1161/ATVBAHA.110.218297</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.110.218297</ArticleId><ArticleId IdType="pubmed">21051662</ArticleId></ArticleIdList></Reference><Reference><Citation>Slevin M, Iemma RS, Zeinolabediny Y, Liu D, Ferris GR, Caprio V, et al. Acetylcholine inhibits monomeric C-reactive protein induced inflammation, endothelial cell adhesion, and platelet aggregation; A potential therapeutic? Front Immunol. (2018) 9:2124. 10.3389/fimmu.2018.02124</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02124</ArticleId><ArticleId IdType="pmc">PMC6168760</ArticleId><ArticleId IdType="pubmed">30319609</ArticleId></ArticleIdList></Reference><Reference><Citation>Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. (1983) 258:7155&#x2013;60. 10.1016/S0021-9258(18)32345-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)32345-7</ArticleId><ArticleId IdType="pubmed">6602130</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HL, Chen CH, Kung CT, Li YC, Sung PH, You HL, et al. Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome. Biomed J. (2019) 42:107&#x2013;15. 10.1016/j.bj.2018.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2018.12.005</ArticleId><ArticleId IdType="pmc">PMC6541877</ArticleId><ArticleId IdType="pubmed">31130246</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size and age determine platelet function independently. Blood. (1984) 63:1372&#x2013;5. 10.1182/blood.V63.6.1372.1372</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V63.6.1372.1372</ArticleId><ArticleId IdType="pubmed">6722354</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett TJ, Lee AH, Xia Y, Lin LH, Black M, Cotzia P, et al. Platelet and vascular biomarkers associate with thrombosis and death in coronavirus disease. Circ Res. (2020) 127:945&#x2013;7. 10.1161/CIRCRESAHA.120.317803</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317803</ArticleId><ArticleId IdType="pmc">PMC7478197</ArticleId><ArticleId IdType="pubmed">32757722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pao CRR, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. (2020) 136:1330&#x2013;41. 10.1182/blood.2020007252</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007252</ArticleId><ArticleId IdType="pmc">PMC7483437</ArticleId><ArticleId IdType="pubmed">32678428</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, et al. Platelet gene expression and function in patients with COVID-19. Blood. (2020) 136:1317&#x2013;29. 10.1182/blood.2020007214</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusudo E, Murata Y, Kawamoto S, Egi M. Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability. Clin Exp Med. (2023):1&#x2013;8. 10.1007/s10238-023-01091-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01091-4</ArticleId><ArticleId IdType="pmc">PMC10198021</ArticleId><ArticleId IdType="pubmed">37208552</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res. (2020) 127:1404&#x2013;18. 10.1161/CIRCRESAHA.120.317703</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor FB, Jr., Toh CH, Hoots WK, Wada H, Levi M, On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. (2001) 86:1327&#x2013;30. 10.1055/s-0037-1616068</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1616068</ArticleId><ArticleId IdType="pubmed">11816725</ArticleId></ArticleIdList></Reference><Reference><Citation>Refaai MA, Riley P, Mardovina T, Bell PD. The clinical significance of fibrin monomers. Thromb Haemost. (2018) 118:1856&#x2013;66. 10.1055/s-0038-1673684</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1673684</ArticleId><ArticleId IdType="pubmed">30312978</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, et al. Intermediate-Dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION randomized trial. Thromb Haemost. (2022) 122:131&#x2013;41. 10.1055/a-1485-2372</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1485-2372</ArticleId><ArticleId IdType="pubmed">33865239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes RD, De Barros ESPGM, Furtado RHM, Macedo AVS, Bronhara B, Damiani LP, et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. (2021) 397:2253&#x2013;63. 10.1016/S0140-6736(21)01203-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01203-4</ArticleId><ArticleId IdType="pmc">PMC8177770</ArticleId><ArticleId IdType="pubmed">34097856</ArticleId></ArticleIdList></Reference><Reference><Citation>Perepu US, Chambers I, Wahab A, Ten Eyck P, Wu C, Dayal S, et al. Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial. J Thromb Haemost. (2021) 19:2225&#x2013;34. 10.1111/jth.15450</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15450</ArticleId><ArticleId IdType="pmc">PMC8420176</ArticleId><ArticleId IdType="pubmed">34236768</ArticleId></ArticleIdList></Reference><Reference><Citation>Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. (2013) 123:958&#x2013;65. 10.1172/JCI64096</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI64096</ArticleId><ArticleId IdType="pmc">PMC3582124</ArticleId><ArticleId IdType="pubmed">23454758</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. (2023) 29:334&#x2013;43. 10.1038/s41591-022-02156-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02156-9</ArticleId><ArticleId IdType="pubmed">36797482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wang L, Liu J, Fu S, Zhou L, Wang Y. Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: a protocol for systematic review and meta-analysis. Medicine (Baltimore). (2022) 101:e28499. 10.1097/MD.0000000000028499</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000028499</ArticleId><ArticleId IdType="pmc">PMC8735775</ArticleId><ArticleId IdType="pubmed">35029905</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichinger S, Warkentin TE, Greinacher A. Thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Reply. N Engl J Med. (2021) 385:e11. 10.1056/NEJMoa2102968</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2102968</ArticleId><ArticleId IdType="pubmed">34133853</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>